Trial NCT01192763

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2011-02523
Secondary IDs: 10-089-A 8522 CDR0000683470 N01CM00071 NCI-2011-02523 U01CA062505

Last trial update was posted on 2013-09-30

MeSH Interventions

2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Adenocarcinoma of the Pancreas Stage IA Pancreatic Cancer Stage IB Pancreatic Cancer Stage IIA Pancreatic Cancer Stage IIB Pancreatic Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID